1. Common Apoc3 Variants And Coronary Artery Disease. (August 2019) Authors: Silbernagel, G.; Scharnagl, H.; Kleber, M.E.; Hoffmann, M.M.; Delgado, G.; Stojakovic, T.; Gary, T.; Zeng, L.; Ritsch, A.; Zewinger, S.; Speer, T.; Schunkert, H.; Landmesser, U.; März, W.; Grammer, T. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Copper, ceruloplasmin, and long-term cardiovascular and total mortality (The Ludwigshafen Risk and Cardiovascular Health Study). (June 2014) Authors: Grammer, T. B.; Kleber, M. E.; Silbernagel, G.; Pilz, S.; Scharnagl, H.; Lerchbaum, E.; Tomaschitz, A.; Koenig, W.; März, W. Journal: Free radical research Issue: Volume 48:Number 6(2014:Jun.) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. C‐reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. (7th May 2014) Authors: Koller, L.; Kleber, M.; Goliasch, G.; Sulzgruber, P.; Scharnagl, H.; Silbernagel, G.; Grammer, T.; Delgado, G.; Tomaschitz, A.; Pilz, S.; März, W.; Niessner, A. Journal: European journal of heart failure Issue: Volume 16:Number 7(2014) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evolving biomarkers improve prediction of long‐term mortality in patients with stable coronary artery disease: the BIO‐VILCAD score. (10th February 2014) Authors: Kleber, M. E.; Goliasch, G.; Grammer, T. B.; Pilz, S.; Tomaschitz, A.; Silbernagel, G.; Maurer, G.; März, W.; Niessner, A. Journal: Journal of internal medicine Issue: Volume 276:Number 2(2014:Aug.) Page Start: 184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HDL cholesterol efflux capacity and cardiovascular mortality. Issue 1 (July 2015) Authors: Ritsch, A.; Duerr, A.; Kahler, P.; Stojakovic, T.; Silbernagel, G.; Scharnagl, H.; Kleber, M.E.; März, W. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High cholesterol absorption is associated with increased cardiovascular risk in hemodialysis patients: Insights from the AURORA study. (August 2022) Authors: Silbernagel, G.; Duarte, K.; Sadiku, S.; Fauler, G.; Maerz, W.; Schmieder, R.E.; Jardine, A.G.; Massy, Z.A.; Girerd, N.; Fellström, B.; Scharnagl, H.; Zannad, F. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Short-term effects of intensive LDL-cholesterol lowering with alirocumab on vascular structure and function. (August 2021) Authors: Metzner, T.; Leitner, D.R.; Dimsity, G.; Gunzer, F.; Opriessnig, P.; Mellitzer, K.; Beck, A.; Sourij, H.; Stojakovic, T.; Deutschmann, H.; März, W.; Landmesser, U.; Brodmann, M.; Reishofer, G.; Scharnagl, H.; Toplak, H.; Silbernagel, G. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗